How many times have we heard it said that one day in America there will be a nationwide health information network that will link patients, providers and payers seamlessly, efficiently and securely, across a universal standardized system?
The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO’s drugs by the end of the decade.
FyrFlyz could be the next big kid craze. The new spinning toy on a string from i-Star Entertainment has earned a spot on a number of “Hot Toy” lists, including the Oppenheim Toy Portfolio and Dr. Toy Top Ten Toys lists.
The market for sports nutrition looks good. All categories grouped by Drug Store News in this space — nutrition and energy bars, energy shots and ready-to-drink protein shakes — currently are trending up significantly.
The cosmetics segment has been on the upswing, and the momentum is likely to continue within the mass market as beauty mavens get increasingly thrifty and do their research when it comes to purchasing makeup.
Technology in retail pharmacies has traditionally meant the adoption of robotic dispensing systems and electronic health records, but in recent years, pharmacy retailers have been bringing technology to the consumer level.
Not a jetpack, but close
RFA Brands has launched Powerbag, a line of bags and backpacks with a built-in charging system for devices ranging from phones to tablets to music players.
Gel manicures are one of the more popular salon services in the professional market, and now beauty mavens can create the look at home — for a fraction of the price — thanks to several new innovations hitting the mass market.
The blood-pressure monitor for the tech-savvy, early-adopter baby boomer generation has arrived. Health Lab recently started distributing its iHealth BP3 blood-pressure monitoring system through Walgreens, Target and Best Buy, among other retailers.
About half of people who provide care and support to loved ones said they are more likely to be nonadherent to their own personal medication regimen than to neglect providing medications to those they are caring for, according to a new study.
The problem with shoplifting these days isn’t Little Johnny pocketing a pack of bubblegum, Joe LaRocca, senior asset protection adviser for the National Retail Federation, recently told CNBC’s “Squawk on the Street” during a broadcast interview.
At the beginning of the year, a major global controversy was settled when it turned out that a study published in The Lancet in 1998 linking the measles-mumps-rubella vaccine to autism in children turned out to be a whopper of a fraud.
As of Oct. 1, Mark Cosby officially stepped into the role of president of CVS/pharmacy. Cosby’s new stint at 1 CVS Dr. is a far cry from his prior role as president of Macy’s stores. But Cosby’s reputation as an innovator is bound to tie in nicely with the Woonsocket, R.I.-based trailblazer.
How much adherence lowers total costs, why some patients do not take their medications as prescribed and whether what’s saved in health care offsets higher drug costs are among the questions that have not been as clearly understood.
“Dispense-as-written” prescriptions are exacerbating medication nonadherence and costing the U.S. healthcare system up to $7.7 billion annually, according to a study by researchers at Harvard University, Brigham and Women’s Hospital, and CVS Caremark.